dc.contributor.author | Arnstad, Ellen Dalen | |
dc.contributor.author | Glerup, Mia | |
dc.contributor.author | Rypdal, Veronika Gjertsen | |
dc.contributor.author | Peltoniemi, Suvi | |
dc.contributor.author | Fasth, Anders | |
dc.contributor.author | Nielsen, Susan | |
dc.contributor.author | Zak, Marek | |
dc.contributor.author | Aalto, Kristiina | |
dc.contributor.author | Berntson, Lillemor | |
dc.contributor.author | Nordal, Ellen Berit | |
dc.contributor.author | Herlin, Troels | |
dc.contributor.author | Romundstad, Pål Richard | |
dc.contributor.author | Rygg, Marite | |
dc.date.accessioned | 2021-07-07T11:08:30Z | |
dc.date.available | 2021-07-07T11:08:30Z | |
dc.date.issued | 2021-03-12 | |
dc.description.abstract | Background: To study fatigue in young adults with juvenile idiopathic arthritis (JIA) 18 years after disease onset,
and to compare with controls.
Methods: Consecutive children with onset of JIA between 1997 and 2000, from geographically defined areas of
Norway, Sweden, Denmark and Finland were followed for 18 years in a close to population-based prospective cohort study. Clinical features, demographic and patient-reported data were collected. Inclusion criteria in the present study were a baseline visit 6 months after disease onset, followed by an 18-year follow-up with available self-reported fatigue score (Fatigue Severity Scale (FSS), 1–7). Severe fatigue was defined as FSS ≥4. For comparison,
Norwegian age and sex matched controls were used.
Results: Among 377 young adults with JIA, 26% reported severe fatigue, compared to 12% among controls. We
found higher burden of fatigue among participants with sleep problems, pain, poor health, reduced participation in
school/work, physical disability, active disease, or use of disease-modifying anti-rheumatic drugs (DMARDs)/
biologics/systemic steroids. In contrast, participants without these challenges, had fatigue scores similar to controls. Active disease assessed at all three time points (baseline, 8-year and 18-year follow-up) was associated with higher mean fatigue score and higher percentage of severe fatigue compared to disease courses characterized by periods of inactive disease. Predictors of fatigue at the 18-year follow-up were female sex and diagnostic delay of ≥6 months at baseline, and also pain, self-reported poor health, active disease, and previous/ongoing use of DMARDs/
biologics at 8 years. | en_US |
dc.identifier.citation | Arnstad, Glerup, Rypdal, Peltoniemi, Fasth, Nielsen, Zak, Aalto, Berntson, Nordal, Herlin, Romundstad, Rygg. Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort. Pediatric Rheumatology. 2021;19 | en_US |
dc.identifier.cristinID | FRIDAID 1916816 | |
dc.identifier.doi | 10.1186/s12969-021-00499-0 | |
dc.identifier.issn | 1546-0096 | |
dc.identifier.uri | https://hdl.handle.net/10037/21814 | |
dc.language.iso | eng | en_US |
dc.publisher | BMC | en_US |
dc.relation.journal | Pediatric Rheumatology | |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2021 The Author(s) | en_US |
dc.subject | VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710 | en_US |
dc.subject | VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710 | en_US |
dc.title | Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |